GWAS is likely to contribute significantly to Alzheimer disease (AD) patients care
Capsule: Genome-wide association studies (GWAS) looking at genetic variants in different individuals may identify variants associated with disease. These cross-national investigations have been applied widely to AD, identifying dozens of “disease-specific” alterations. Is the huge and expensive investment likely to help find a cure for AD?
Yes:John Hardy, UK
No: Amos Korczyn, Israel
Discussions and rebuttals
Thomas Willis and the first decade of the brai Alastair Compston, UK